Global Retirement Partners’s Recursion Pharmaceuticals RXRX Stock Holding History

Global Retirement Partners’s Portfolio RXRX Stock Details RXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$213K	Buy	52,088 +1,543	+3%	+$7.64K	﹤0.01%	1438
2025 Q3	$247K	Buy	50,545 +19,748	+64%	+$104K	0.01%	1072
2025 Q2	$156K	Buy	+30,797	New	+$151K	﹤0.01%	1213
2024 Q4	$212K	Buy	31,297 +7,500	+32%	+$50.4K	0.01%	925
2024 Q3	$157K	Buy	23,797 +8,750	+58%	+$62.7K	﹤0.01%	1019
2024 Q2	$113K	Buy	15,047 +13,547	+903%	+$118K	﹤0.01%	1126
2024 Q1	$15K	Buy	1,500 +1,200	+400%	+$13.4K	﹤0.01%	1936
2023 Q4	$3.23K	Hold	300	–	–	﹤0.01%	2486
2023 Q3	$2.15K	Buy	+300	New	+$2.99K	﹤0.01%	2514

Other funds holding RXRX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MCMU

MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Global Retirement Partners's RXRX Position: Q4 2025 in Review

Global Retirement Partners increased its Recursion Pharmaceuticals (RXRX) stake by 3.1% in Q4 2025, buying an estimated $7.64K and bringing the position to 52,088 shares worth $213K. The position accounts for ﹤0.01% of the portfolio, ranked #1438.

Global Retirement Partners first reported a position in RXRX in Q3 2023 and has held it in 9 quarters since. The position peaked at $247K in Q3 2025. 333 funds tracked by Wall St. Rank hold RXRX as of Q4 2025.

Global Retirement Partners held 52,088 shares of Recursion Pharmaceuticals worth $213K as of Q4 2025.
Global Retirement Partners bought 1,543 Recursion Pharmaceuticals shares in Q4 2025, an estimated $7.64K.
Recursion Pharmaceuticals made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #1438 holding.
Global Retirement Partners first reported a position in Recursion Pharmaceuticals in Q3 2023 and has held it in 9 quarters since.
Global Retirement Partners's Recursion Pharmaceuticals position peaked at $247K in Q3 2025.
333 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.